We are live on
!
Find out more
RI
Ridgewood Investments Portfolio holdings
AUM
$267M
This Fund
S&P 500
This Quarter
Est. Return
+4.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$22.7M
(+16%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
833
New
632
Increased
56
Reduced
89
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.48M |
| 2 |
ALPS Medical Breakthroughs ETF
SBIO
|
+$851K |
| 3 |
RB Global
RBA
|
+$600K |
| 4 |
Baxter International
BAX
|
+$535K |
| 5 |
International Flavors & Fragrances
IFF
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$955K |
| 2 |
Cardinal Health
CAH
|
+$806K |
| 3 |
Deere & Co
DE
|
+$621K |
| 4 |
Kimberly-Clark
KMB
|
+$594K |
| 5 |
Goldman Sachs
GS
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.03% |
| 2 | Healthcare | 10.58% |
| 3 | Technology | 8.88% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Helmerich & Payne
HP
$3.71B
| $130K | 0.08% |
3,632
-2,500
| -41% | -$108K |
|
227
CRA International
CRAI
$1.06B
| $129K | 0.08% |
+1,200
| New | +$141K |
|
228
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
| $127K | 0.08% |
+5,482
| New | +$128K |
|
229
Spotify
SPOT
$100B
| $126K | 0.08% |
+944
| New | +$108K |
|
230
British American Tobacco
BTI
$128B
| $125K | 0.08% |
3,568
+2,515
| +239% | +$94.8K |
|
231
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $125K | 0.08% |
+1,065
| New | +$124K |
|
232
Nucor
NUE
$62.1B
| $124K | 0.08% |
+803
| New | +$128K |
|
233
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $122K | 0.07% |
+1,118
| New | +$121K |
|
234
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $121K | 0.07% |
+1,472
| New | +$120K |
|
235
Costco
COST
$420B
| $117K | 0.07% |
+236
| New | +$116K |
|
236
Clorox
CLX
$12.7B
| $116K | 0.07% |
731
-1,636
| -69% | -$245K |
|
237
State Street
STT
$50.7B
| $114K | 0.07% |
+1,512
| New | +$127K |
|
238
Vanguard Real Estate ETF
VNQ
$39.1B
| $114K | 0.07% |
+1,367
| New | +$117K |
|
239
Biomerica
BMRA
$4.98M
| $112K | 0.07% |
7,500
| – | – |
|
|
ATVI
240
DELISTED
Activision Blizzard
ATVI
| $111K | 0.07% |
1,302
-5,198
| -80% | -$404K |
|
241
Cboe Global Markets
CBOE
$29.9B
| $111K | 0.07% |
830
-776
| -48% | -$97.4K |
|
242
RTX Corp
RTX
$301B
| $109K | 0.07% |
1,118
-1,000
| -47% | -$98.5K |
|
243
PepsiCo
PEP
$190B
| $109K | 0.07% |
596
-885
| -60% | -$155K |
|
244
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $107K | 0.07% |
+2,118
| New | +$106K |
|
245
Synopsys
SNPS
$79.7B
| $105K | 0.06% |
+271
| New | +$96.8K |
|
246
Coinbase
COIN
$40.5B
| $104K | 0.06% |
+1,546
| New | +$92.6K |
|
247
Emergent Biosolutions
EBS
$248M
| $104K | 0.06% |
10,004
| – | – |
|
248
Allstate
ALL
$67.5B
| $103K | 0.06% |
+933
| New | +$118K |
|
249
Haleon
HLN
$44.2B
| $103K | 0.06% |
12,688
-1,403
| -10% | -$11.2K |
|
250
dLocal
DLO
$4.24B
| $102K | 0.06% |
+6,296
| New | +$99.1K |
|
Similar funds
IP
CFG
EU
PC
TGI
TWM
SP
EAIC
Ridgewood Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Ridgewood Investments held 833 positions worth $163M, up 16% from $141M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ridgewood Investments deployed $22.4M of net new capital in Q1 2023, opening 632 new positions and adding to 56 existing holdings. Its largest new stake was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $955K trimmed.
- Ridgewood Investments's largest Q1 2023 buy was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
- Ridgewood Investments added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $3.48M increase.
- Ridgewood Investments's biggest Q1 2023 reduction was Gilead Sciences, cutting an estimated $955K.
- Ridgewood Investments fully exited SRAX, Inc. Class A Common Stock in Q1 2023, selling an estimated $278K.
- Ridgewood Investments's ten largest holdings make up 24% of its $163M portfolio in Q1 2023.
- Ridgewood Investments opened 632 new positions and closed 4 in Q1 2023.
- Ridgewood Investments's portfolio value rose 16% quarter-over-quarter to $163M.
Based on Ridgewood Investments's 13F filing for Q1 2023, filed 25 Apr 2023.